SCHEMBL235441

SCHEMBL235441

O=NN[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.67
GSTK1 Q9Y2Q3 1/20 0.67
GLO1 Q04760 4/20 0.47
FOLH1 Q04609 2/20 0.43
NOD1 Q9Y239 2/20 0.37
FNTA P49354 3/20 0.36
FNTB P49356 3/20 0.36
PGGT1B P53609 1/20 0.36
ACE P12821 1/20 0.36
MAPT P10636 2/20 0.35
PTGS2 P35354 2/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
RIMKLA Q8IXN7 1/20 0.35
NAALAD2 Q9Y3Q0 1/20 0.35
KDM4E B2RXH2 1/20 0.35
THRB P10828 1/20 0.35
ALOX15 P16050 1/20 0.35
NFKB1 P19838 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25261524 1.00 PTGS1 (0.67) PTGS1GSTK1GLO1FOLH1NOD1
Hydrogen Sulfide SCHEMBL25261722 0.99 PTGS1 (0.66) PTGS1GSTK1GLO1FOLH1NOD1
SCHEMBL27716497 0.88 PTGS1 (0.66) PTGS1GSTK1GLO1FOLH1NOD1
SCHEMBL8591694 0.88 PTGS1 (0.66) PTGS1GSTK1GLO1FOLH1NOD1
Taurine SCHEMBL28497670 0.88 PTGS1 (0.57) PTGS1GSTK1GLO1FOLH1NOD1
SCHEMBL27490732 0.87 PTGS1 (0.72) PTGS1GSTK1GLO1FOLH1NOD1
SCHEMBL29559136 0.87 PTGS1 (0.72) PTGS1GSTK1GLO1FOLH1NOD1
SCHEMBL17629937 0.86 PTGS1 (0.67) PTGS1GSTK1GLO1FOLH1NOD1
SCHEMBL29623583 0.86 PTGS1 (0.71) PTGS1GSTK1GLO1FOLH1NOD1
SCHEMBL1332941 0.86 PTGS1 (0.71) PTGS1GSTK1GLO1FOLH1NOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 884 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250288607-A1 METHODS FOR TREATING SEXUAL DYSFUNCTION ASSOCIATED WITH POLYCYSTIC OVARY SYNDROME (PCOS) OR WITH HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) Institut National de la Santé et de la Recherche Médicale (FR) 2025-09-18 US claimed
EP-4522146-A1 METHODS FOR TREATING SEXUAL DYSFUNCTION ASSOCIATED WITH POLYCYSTIC OVARY SYNDROME (PCOS) OR WITH HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) Institut National de la Santé et de la Recherche Médicale (FR) 2025-03-19 EP claimed
CN-119055582-A Quick-dissolving microneedle patch capable of improving androgenetic alopecia and preparation method and application thereof 西北大学 2024-12-03 CN claimed
WO-2024151479-A1 CONTAINERS AND METHODS FOR NITRIC OXIDE STERILIZATION STERILE STATE, LLC (US) 2024-07-18 WO claimed
EP-4384272-A1 ANTIBACTERIAL PORPHYRIN NANOPARTICLES AND METHODS FOR MAKING AND USING THE SAME University of Georgia Research Foundation, Inc. (US) 2024-06-19 EP claimed
CN-118021752-A Mitochondrial targeting immunostimulation nano-drug capable of crossing blood brain barrier 山东大学齐鲁医院 2024-05-14 CN claimed
US-20240091552-A1 SYSTEMS AND METHODS FOR PHOTOTHERAPEUTIC MODULATION OF NITRIC OXIDE FP VENTURE DEBT I BETA LTD (CY) 2024-03-21 US claimed
WO-2024052927-A1 NOVEL POLYMERIC FILM AND PAPER BASED PACKAGING SYSTEM TO DECELERATE SENESCENCE OF CLIMACTERIC AND NON-CLIMACTERIC HORTICULTURE PRODUCE ORIENT PRESS LIMITED (IN) 2024-03-14 WO claimed
EP-4304717-A1 USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY Chronic Airway Therapeutics Limited (AU) 2024-01-17 EP claimed
EP-4301340-A1 MICELLE RELEASING THERMOSENSITIVE HYDROGELS AS A THERAPEUTIC DELIVERY SYSTEM Georgia Tech Research Corporation (US) 2024-01-10 EP claimed
WO-2001085013-A2 INFRARED THERMOGRAPHY AND METHODS OF USE NITROMED, INC. (US) 2001-11-15 WO claimed
WO-2001070199-A1 MATRICES CONTAINING NITRIC OXIDE DONORS AND REDUCING AGENTS AND THEIR USE NOVOVASCULAR, INC. (US) 2001-09-27 WO claimed
US-20010012834-A1 Treating pulmonary disorders with gaseous agent causing repletion of GSNO DUKE UNIVERSITY (US) 2001-08-09 US claimed
WO-2001017596-A1 METHOD OF TREATING CARDIO PULMONARY DISEASES WITH NO GROUP COMPOUNDS DUKE UNIVERSITY (US) 2001-03-15 WO claimed
US-6159500-A Pharmaceutical preparations of glutathione and methods of administration thereof ANTIOXIDANT PHARMACEUTICALS CORPORATION (US) 2000-12-12 US claimed
EP-0957901-A1 PHARMACEUTICAL PREPARATIONS OF GLUTATHIONE AND METHODS OF ADMINISTRATION THEREOF Antioxidant Pharmaceuticals Corporation (US) 1999-11-24 EP claimed
EP-0914348-A1 POLYMERS FOR DELIVERING NITRIC OXIDE IN VIVO DUKE UNIVERSITY MEDICAL CENTER (US) 1999-05-12 EP claimed
WO-1998029101-A1 PHARMACEUTICAL PREPARATIONS OF GLUTATHIONE AND METHODS OF ADMINISTRATION THEREOF ANTIOXIDANT PHARMACEUTICALS CORPORATION (US) 1998-07-09 WO claimed
WO-1998005689-A1 POLYMERS FOR DELIVERING NITRIC OXIDE IN VIVO DUKE UNIVERSITY MEDICAL CENTER (US) 1998-02-12 WO claimed
US-5626738-A Methods for the separation and detection of nitrosothiols AMERICAN HEALTH FOUNDATION (US) 1997-05-06 US claimed